EMEA (Europe, Middle East and Africa) Nanomedicine Market Report 2017

October 2017 | 113 pages | ID: ECA89886E89PEN
QYResearch

Abstracts

In this report, the EMEA Nanomedicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Nanomedicine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Nanomedicine market competition by top manufacturers/players, with Nanomedicine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• GE Healthcare
• Johnson & Johnson
• Mallinckrodt plc
• Merck & Co. Inc.
• Nanosphere Inc.
• Pfizer Inc.
• Sigma-Tau Pharmaceuticals Inc.
• Smith & Nephew PLC
• Stryker Corp
• Teva Pharmaceutical Industries Ltd.
• UCB (Union chimique belge) S.A

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Regenerative Medicine
• In-vitro & In-vivo Diagnostics
• Vaccines
• Drug Delivery

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Nanomedicine for each application, including

• Clinical Cardiology
• Urology
• Genetics
• Orthopedics
• Ophthalmology

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Nanomedicine Market Report 2017

1 NANOMEDICINE OVERVIEW

1.1 Product Overview and Scope of Nanomedicine
1.2 Classification of Nanomedicine
  1.2.1 EMEA Nanomedicine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Nanomedicine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Regenerative Medicine
  1.2.4 In-vitro & In-vivo Diagnostics
  1.2.5 Vaccines
  1.2.6 Drug Delivery
1.3 EMEA Nanomedicine Market by Application/End Users
  1.3.1 EMEA Nanomedicine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Clinical Cardiology
  1.3.3 Urology
  1.3.4 Genetics
  1.3.5 Orthopedics
  1.3.6 Ophthalmology
1.4 EMEA Nanomedicine Market by Region
  1.4.1 EMEA Nanomedicine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Nanomedicine (2012-2022)
  1.5.1 EMEA Nanomedicine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Nanomedicine Revenue and Growth Rate (2012-2022)

2 EMEA NANOMEDICINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Nanomedicine Market Competition by Players/Manufacturers
  2.1.1 EMEA Nanomedicine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Nanomedicine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Nanomedicine Sale Price by Players (2012-2017)
2.2 EMEA Nanomedicine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Nanomedicine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Nanomedicine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Nanomedicine Sale Price by Type (2012-2017)
2.3 EMEA Nanomedicine (Volume) by Application
2.4 EMEA Nanomedicine (Volume and Value) by Region
  2.4.1 EMEA Nanomedicine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Nanomedicine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Nanomedicine Sales Price by Region (2012-2017)

3 EUROPE NANOMEDICINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Nanomedicine Sales and Value (2012-2017)
  3.1.1 Europe Nanomedicine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Nanomedicine Revenue and Growth Rate (2012-2017)
3.2 Europe Nanomedicine Sales and Market Share by Type
3.3 Europe Nanomedicine Sales and Market Share by Application
3.4 Europe Nanomedicine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Nanomedicine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Nanomedicine Revenue by Countries (2012-2017)
  3.4.3 Germany Nanomedicine Sales and Growth Rate (2012-2017)
  3.4.4 France Nanomedicine Sales and Growth Rate (2012-2017)
  3.4.5 UK Nanomedicine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Nanomedicine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Nanomedicine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Nanomedicine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NANOMEDICINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Nanomedicine Sales and Value (2012-2017)
  4.1.1 Middle East Nanomedicine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Nanomedicine Revenue and Growth Rate (2012-2017)
4.2 Middle East Nanomedicine Sales and Market Share by Type
4.3 Middle East Nanomedicine Sales and Market Share by Application
4.4 Middle East Nanomedicine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Nanomedicine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Nanomedicine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Nanomedicine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Nanomedicine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Nanomedicine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Nanomedicine Sales and Growth Rate (2012-2017)

5 AFRICA NANOMEDICINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Nanomedicine Sales and Value (2012-2017)
  5.1.1 Africa Nanomedicine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Nanomedicine Revenue and Growth Rate (2012-2017)
5.2 Africa Nanomedicine Sales and Market Share by Type
5.3 Africa Nanomedicine Sales and Market Share by Application
5.4 Africa Nanomedicine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Nanomedicine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Nanomedicine Revenue by Countries (2012-2017)
  5.4.3 South Africa Nanomedicine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Nanomedicine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Nanomedicine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Nanomedicine Sales and Growth Rate (2012-2017)

6 EMEA NANOMEDICINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 GE Healthcare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nanomedicine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GE Healthcare Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Nanomedicine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Johnson & Johnson Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Mallinckrodt plc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Nanomedicine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Mallinckrodt plc Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co. Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Nanomedicine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck & Co. Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Nanosphere Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Nanomedicine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Nanosphere Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Nanomedicine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sigma-Tau Pharmaceuticals Inc.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Nanomedicine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sigma-Tau Pharmaceuticals Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Smith & Nephew PLC
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Nanomedicine Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Smith & Nephew PLC Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Stryker Corp
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Nanomedicine Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Stryker Corp Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Teva Pharmaceutical Industries Ltd.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Nanomedicine Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Teva Pharmaceutical Industries Ltd. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 UCB (Union chimique belge) S.A

7 NANOMEDICINE MANUFACTURING COST ANALYSIS

7.1 Nanomedicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nanomedicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nanomedicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nanomedicine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NANOMEDICINE MARKET FORECAST (2017-2022)

11.1 EMEA Nanomedicine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Nanomedicine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Nanomedicine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Nanomedicine Price and Trend Forecast (2017-2022)
11.2 EMEA Nanomedicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Nanomedicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Nanomedicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Nanomedicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Nanomedicine Sales Forecast by Type (2017-2022)
11.7 EMEA Nanomedicine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Nanomedicine
Figure EMEA Nanomedicine Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Nanomedicine Sales Volume Market Share by Type (Product Category) in 2016
Figure Regenerative Medicine Product Picture
Figure In-vitro & In-vivo Diagnostics Product Picture
Figure Vaccines Product Picture
Figure Drug Delivery Product Picture
Figure EMEA Nanomedicine Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Nanomedicine by Application in 2016
Figure Clinical Cardiology Examples
Table Key Downstream Customer in Clinical Cardiology
Figure Urology Examples
Table Key Downstream Customer in Urology
Figure Genetics Examples
Table Key Downstream Customer in Genetics
Figure Orthopedics Examples
Table Key Downstream Customer in Orthopedics
Figure Ophthalmology Examples
Table Key Downstream Customer in Ophthalmology
Figure EMEA Nanomedicine Market Size (Million USD) by Region (2012-2022)
Figure Europe Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Nanomedicine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Nanomedicine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Nanomedicine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Nanomedicine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Nanomedicine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Nanomedicine Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Nanomedicine Sales Share by Players (2012-2017)
Figure 2016 Nanomedicine Sales Share by Players
Figure 2017 Nanomedicine Sales Share by Players
Figure EMEA Nanomedicine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Nanomedicine Revenue (Million USD) by Players (2012-2017)
Table EMEA Nanomedicine Revenue Share by Players (2012-2017)
Table 2016 EMEA Nanomedicine Revenue Share by Players
Table 2017 EMEA Nanomedicine Revenue Share by Players
Table EMEA Nanomedicine Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Nanomedicine Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Nanomedicine Sales Share by Type (2012-2017)
Figure Sales Market Share of Nanomedicine by Type (2012-2017)
Figure EMEA Nanomedicine Sales Market Share by Type (2012-2017)
Table EMEA Nanomedicine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Nanomedicine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nanomedicine by Type in 2016
Table EMEA Nanomedicine Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Nanomedicine Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Nanomedicine Sales Share by Application (2012-2017)
Figure Sales Market Share of Nanomedicine by Application (2012-2017)
Figure EMEA Nanomedicine Sales Market Share by Application in 2016
Table EMEA Nanomedicine Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Nanomedicine Sales Share by Region (2012-2017)
Figure Sales Market Share of Nanomedicine by Region (2012-2017)
Figure EMEA Nanomedicine Sales Market Share in 2016
Table EMEA Nanomedicine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Nanomedicine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Nanomedicine by Region (2012-2017)
Figure EMEA Nanomedicine Revenue Market Share Regions in 2016
Table EMEA Nanomedicine Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Nanomedicine Revenue and Growth Rate (2012-2017)
Table Europe Nanomedicine Sales (K Units) by Type (2012-2017)
Table Europe Nanomedicine Market Share by Type (2012-2017)
Figure Europe Nanomedicine Market Share by Type in 2016
Table Europe Nanomedicine Sales (K Units) by Application (2012-2017)
Table Europe Nanomedicine Market Share by Application (2012-2017)
Figure Europe Nanomedicine Market Share by Application in 2016
Table Europe Nanomedicine Sales (K Units) by Countries (2012-2017)
Table Europe Nanomedicine Sales Market Share by Countries (2012-2017)
Figure Europe Nanomedicine Sales Market Share by Countries (2012-2017)
Figure Europe Nanomedicine Sales Market Share by Countries in 2016
Table Europe Nanomedicine Revenue (Million USD) by Countries (2012-2017)
Table Europe Nanomedicine Revenue Market Share by Countries (2012-2017)
Figure Europe Nanomedicine Revenue Market Share by Countries (2012-2017)
Figure Europe Nanomedicine Revenue Market Share by Countries in 2016
Figure Germany Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure France Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure UK Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nanomedicine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Nanomedicine Sales (K Units) by Type (2012-2017)
Table Middle East Nanomedicine Market Share by Type (2012-2017)
Figure Middle East Nanomedicine Market Share by Type (2012-2017)
Table Middle East Nanomedicine Sales (K Units) by Applications (2012-2017)
Table Middle East Nanomedicine Market Share by Applications (2012-2017)
Figure Middle East Nanomedicine Sales Market Share by Application in 2016
Table Middle East Nanomedicine Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Nanomedicine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Nanomedicine Sales Volume Market Share by Countries in 2016
Table Middle East Nanomedicine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Nanomedicine Revenue Market Share by Countries (2012-2017)
Figure Middle East Nanomedicine Revenue Market Share by Countries (2012-2017)
Figure Middle East Nanomedicine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nanomedicine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Nanomedicine Sales (K Units) by Type (2012-2017)
Table Africa Nanomedicine Sales Market Share by Type (2012-2017)
Figure Africa Nanomedicine Sales Market Share by Type (2012-2017)
Figure Africa Nanomedicine Sales Market Share by Type in 2016
Table Africa Nanomedicine Sales (K Units) by Application (2012-2017)
Table Africa Nanomedicine Sales Market Share by Application (2012-2017)
Figure Africa Nanomedicine Sales Market Share by Application (2012-2017)
Table Africa Nanomedicine Sales Volume (K Units) by Countries (2012-2017)
Table Africa Nanomedicine Sales Market Share by Countries (2012-2017)
Figure Africa Nanomedicine Sales Market Share by Countries (2012-2017)
Figure Africa Nanomedicine Sales Market Share by Countries in 2016
Table Africa Nanomedicine Revenue (Million USD) by Countries (2012-2017)
Table Africa Nanomedicine Revenue Market Share by Countries (2012-2017)
Figure Africa Nanomedicine Revenue Market Share by Countries (2012-2017)
Figure Africa Nanomedicine Revenue Market Share by Countries in 2016
Figure South Africa Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Table GE Healthcare Nanomedicine Basic Information List
Table GE Healthcare Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure GE Healthcare Nanomedicine Sales Market Share in EMEA (2012-2017)
Figure GE Healthcare Nanomedicine Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Nanomedicine Basic Information List
Table Johnson & Johnson Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Nanomedicine Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Nanomedicine Revenue Market Share in EMEA (2012-2017)
Table Mallinckrodt plc Nanomedicine Basic Information List
Table Mallinckrodt plc Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mallinckrodt plc Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Mallinckrodt plc Nanomedicine Sales Market Share in EMEA (2012-2017)
Figure Mallinckrodt plc Nanomedicine Revenue Market Share in EMEA (2012-2017)
Table Merck & Co. Inc. Nanomedicine Basic Information List
Table Merck & Co. Inc. Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Inc. Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Merck & Co. Inc. Nanomedicine Sales Market Share in EMEA (2012-2017)
Figure Merck & Co. Inc. Nanomedicine Revenue Market Share in EMEA (2012-2017)
Table Nanosphere Inc. Nanomedicine Basic Information List
Table Nanosphere Inc. Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Nanosphere Inc. Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Nanosphere Inc. Nanomedicine Sales Market Share in EMEA (2012-2017)
Figure Nanosphere Inc. Nanomedicine Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc. Nanomedicine Basic Information List
Table Pfizer Inc. Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc. Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Inc. Nanomedicine Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc. Nanomedicine Revenue Market Share in EMEA (2012-2017)
Table Sigma-Tau Pharmaceuticals Inc. Nanomedicine Basic Information List
Table Sigma-Tau Pharmaceuticals Inc. Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sigma-Tau Pharmaceuticals Inc. Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Sigma-Tau Pharmaceuticals Inc. Nanomedicine Sales Market Share in EMEA (2012-2017)
Figure Sigma-Tau Pharmaceuticals Inc. Nanomedicine Revenue Market Share in EMEA (2012-2017)
Table Smith & Nephew PLC Nanomedicine Basic Information List
Table Smith & Nephew PLC Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Smith & Nephew PLC Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Smith & Nephew PLC Nanomedicine Sales Market Share in EMEA (2012-2017)
Figure Smith & Nephew PLC Nanomedicine Revenue Market Share in EMEA (2012-2017)
Table Stryker Corp Nanomedicine Basic Information List
Table Stryker Corp Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Stryker Corp Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Stryker Corp Nanomedicine Sales Market Share in EMEA (2012-2017)
Figure Stryker Corp Nanomedicine Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceutical Industries Ltd. Nanomedicine Basic Information List
Table Teva Pharmaceutical Industries Ltd. Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Nanomedicine Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Nanomedicine Sales Market Share in EMEA (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Nanomedicine Revenue Market Share in EMEA (2012-2017)
Table UCB (Union chimique belge) S.A Nanomedicine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nanomedicine
Figure Manufacturing Process Analysis of Nanomedicine
Figure Nanomedicine Industrial Chain Analysis
Table Raw Materials Sources of Nanomedicine Major Manufacturers in 2016
Table Major Buyers of Nanomedicine
Table Distributors/Traders List
Figure EMEA Nanomedicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Nanomedicine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Nanomedicine Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Nanomedicine Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Nanomedicine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Nanomedicine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Nanomedicine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Nanomedicine Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Nanomedicine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Nanomedicine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Nanomedicine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Nanomedicine Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Nanomedicine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Nanomedicine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Nanomedicine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Nanomedicine Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Nanomedicine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Nanomedicine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Nanomedicine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Nanomedicine Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Nanomedicine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Nanomedicine Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Nanomedicine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources